企业邮箱
Just the End of 2010, with the Good Fortune of 2011, Another MEBO Product Was Officially Admitted by International Market
2011年-01月-30日
来源：MEBO
On Jan 28th, 2011, it was pleased to be told that Certificate of Pharmaceutical Product by UAE Health Ministry was given to MEBO Scar Ointment. This certificate means the good therapeutic effect of MEBO Scar Ointment in the treatment of wound and scar is wildly approved as well as the entrance into a wholly new platform for MEBO Scar Ointment in UAE market with the openness of another new passageway to the marketing development of Middle East and North Africa.
MEBO Scar Ointment is one of the most important products in the series of MEBO regenerative products. In the last years, it has been wildly approved in UAE through its superior quality, just like MEBO Wound Ointment as the star product knowing at every corner in UAE.
However, from 2005 to now, MEBO Scar Ointment has always been sold as the cosmetic in UAE. Due to the restriction by local legal rules that the therapeutic effect in wound and trauma treatment can not be used in propaganda, the marketing expansion and extension in clinical indications have been limited greatly.
At the beginning of 2010, Julphar Pharmaceutical Cooperation and the top management of MEBO International Marketing Group made the business discussion that confirmed the strategic position of MEBO Scar Ointment in oversea market and started the registration procedure as the medication in order to make it as a new MEBO star product and develop the scar market as large as MEBO Wound Ointment in UAE. After the efforts and the delicate preparation paid by different directions including the repeating discussion, idea exchange, amendment and drafting of the submitting material, ultimately MEBO Scar Ointment was given the Certificate of Pharmaceutical Product under the entire cooperation and coordination of Julpar and MEBO International Marketing Group.
The obtaining of CPP is rising up the marketing position of MEBO Scar Ointment and expanding the sale range. With the extended range of sales and product promotion, it can be directly propagandizing the regenerative effect of this product and conducting extensive clinical trial and the complement of indication with the utilization of large amounts of accumulated clinical cases and papers. All of above can not be realized while MEBO Scar Ointment acts as a role of cosmetic.
The acquirement of UAE CPP not only means a pass for MEBO Scar Ointment as pharmaceutical product selling in UAE, but also has the significant and key functions to the marketing development in the entire Middle East and North Africa. With the continuous promotion of international marketing, MEBO Scar Ointment will be put onto the good shelf in more than 60 countries in the following 3 to 5 years. Beside, it will definitely be another star in the series of MEBO regenerative products, thus enabling and dragging the scar-treating market with limitless prosperity.
MEBO Scar Ointment is one of the most important products in the series of MEBO regenerative products. In the last years, it has been wildly approved in UAE through its superior quality, just like MEBO Wound Ointment as the star product knowing at every corner in UAE.
However, from 2005 to now, MEBO Scar Ointment has always been sold as the cosmetic in UAE. Due to the restriction by local legal rules that the therapeutic effect in wound and trauma treatment can not be used in propaganda, the marketing expansion and extension in clinical indications have been limited greatly.
At the beginning of 2010, Julphar Pharmaceutical Cooperation and the top management of MEBO International Marketing Group made the business discussion that confirmed the strategic position of MEBO Scar Ointment in oversea market and started the registration procedure as the medication in order to make it as a new MEBO star product and develop the scar market as large as MEBO Wound Ointment in UAE. After the efforts and the delicate preparation paid by different directions including the repeating discussion, idea exchange, amendment and drafting of the submitting material, ultimately MEBO Scar Ointment was given the Certificate of Pharmaceutical Product under the entire cooperation and coordination of Julpar and MEBO International Marketing Group.
The obtaining of CPP is rising up the marketing position of MEBO Scar Ointment and expanding the sale range. With the extended range of sales and product promotion, it can be directly propagandizing the regenerative effect of this product and conducting extensive clinical trial and the complement of indication with the utilization of large amounts of accumulated clinical cases and papers. All of above can not be realized while MEBO Scar Ointment acts as a role of cosmetic.
The acquirement of UAE CPP not only means a pass for MEBO Scar Ointment as pharmaceutical product selling in UAE, but also has the significant and key functions to the marketing development in the entire Middle East and North Africa. With the continuous promotion of international marketing, MEBO Scar Ointment will be put onto the good shelf in more than 60 countries in the following 3 to 5 years. Beside, it will definitely be another star in the series of MEBO regenerative products, thus enabling and dragging the scar-treating market with limitless prosperity.